Stericon Pharma Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Stericon Pharma Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $1.1M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Stericon Pharma Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $1.1M Trade | TransData Nexus

Stericon Pharma Private Limited

Indian Pharmaceutical Exporter · Ayurvedic & Herbal Products Specialist · $1.1M Total Trade · DGFT Verified

Stericon Pharma Private Limited is an Indian pharmaceutical exporter with a total trade value of $1.1M across 2 products in 1 therapeutic categories. Based on 33 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Vati ($639.5K), Natural ($411.0K), .

Stericon Pharma Private Limited — Export Portfolio & Destination Treemap

Stericon Pharma Private Limited pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Stericon Pharma Private Limited? — Company Overview & Market Position

Stericon Pharma Private Limited, established on July 10, 1990, is a privately held pharmaceutical company headquartered in Bangalore, Karnataka, India. The company is registered under the Corporate Identification Number (CIN) U33201KA1990PTC011056. As of the latest available data, Stericon Pharma has an authorized share capital of ₹47.5 million and a paid-up capital of ₹43.7 million. The company is classified as a non-government entity and operates in the manufacturing sector, specifically in the production of medical and optical instruments.

In the fiscal year ending March 31, 2024, Stericon Pharma reported a net sales revenue growth of 24.51%, indicating a positive financial trajectory. The company's operating profit margin (ROS) improved by 10.81%, and the net profit margin increased by 8.14%, reflecting enhanced operational efficiency. The return on equity (ROE) stood at 5.97%, suggesting effective utilization of shareholder funds.

What Does Stericon Pharma Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Vati$639.5K 2

Product Portfolio — Top 2 by Export Value

Stericon Pharma Private Limited exports 2 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Vati	Ayurvedic & Herbal Products	$639.5K	15	2.4%	8
2	Natural	Ayurvedic & Herbal Products	$411.0K	18	1.6%	12

Stericon Pharma Private Limited exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $1.1M. The top category is Ayurvedic & Herbal Products (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Stericon Pharma Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Stericon Pharma operates a state-of-the-art manufacturing facility located in the Bommasandra Industrial Area of Bangalore, Karnataka. The facility is ISO 13485 certified by DNV GL Presafe, Norway, ensuring compliance with international quality management standards for medical devices. Additionally, the company's contact lens cleaning solutions are CE certified, authorizing their marketing within the European Union. The manufacturing plant specializes in the production of sterile multipurpose contact lens cleaning solutions and sterile eye and nasal formulations.

3Key Leadership

As of March 2026, the board of directors of Stericon Pharma Private Limited comprises:

Ajay Bhushanlal Khushu
Chinmay Rajesh Vasa
Amar Narendrabhai Shah

These directors are responsible for steering the company's strategic direction and ensuring adherence to regulatory standards.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Stericon Pharma Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Stericon Pharma's products are CE certified, allowing them to be marketed within the European Union. This certification indicates compliance with the European Medical Device Directive, facilitating access to EU markets. The company's contact lens cleaning solutions are also BRC (British Retail Consortium) certified by SGS, UK, enabling supply to UK retail chains through strategic alliances.

2Emerging Markets

Stericon Pharma has expanded its presence to over 48 countries, including regions in Africa, Latin America, and Southeast Asia. The company's commitment to quality is demonstrated by its ISO 13485 certification and CE marking, which are recognized internationally and facilitate market access in these emerging regions.

3Geographic Strategy

Stericon Pharma's strategic focus on international markets, particularly in Europe and emerging economies, indicates a diversification strategy aimed at reducing dependence on any single market. The company's certifications and quality standards support this approach, mitigating concentration risks and positioning Stericon Pharma for sustained growth.

Stericon Pharma Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

As of March 2026, there is no publicly available information indicating that Stericon Pharma has FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, or a history of FDA inspections. This suggests that the company may not currently market its products in the United States or has not pursued FDA approvals for its pharmaceutical formulations.

2WHO & EU GMP

Stericon Pharma's manufacturing facility is ISO 13485 certified, ensuring compliance with international quality management standards for medical devices. The company's contact lens cleaning solutions are CE certified, authorizing their marketing within the European Union. However, there is no publicly available information confirming WHO prequalification or EU Good Manufacturing Practice (GMP) certificates for the company's pharmaceutical products.

3CDSCO & Indian Regulatory

Stericon Pharma holds an AYUSH license, allowing it to manufacture Ayurvedic, Yoga, Naturopathy, Unani, Siddha, and Homeopathy products. The company manufactures eye and nasal preparations for Himalaya Healthcare India under this license. Additionally, Stericon Pharma has drug licenses for more than 200 products and can apply for new licenses based on customer requirements.

Stericon Pharma Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Stericon Pharma operates in the pharmaceutical manufacturing sector, specializing in sterile eye and nasal formulations. While specific competitors are not identified in the available data, the company's certifications, such as ISO 13485 and CE marking, position it favorably in the market. These certifications enable access to regulated markets and enhance the company's competitive edge.

2Key Differentiators

Stericon Pharma's key differentiators include its ISO 13485 certification, CE marking, and BRC certification, which underscore its commitment to quality and compliance with international standards. The company's extensive experience in manufacturing sterile eye and nasal formulations, along with its capability to produce over 200 products, further distinguishes it in the market.

3Strategic Position

Stericon Pharma's strategic direction focuses on manufacturing sterile eye and nasal formulations, with a strong emphasis on quality and compliance. The company's certifications and international presence indicate a commitment to expanding its footprint in regulated markets. Future outlooks would benefit from pursuing additional certifications, such as WHO prequalification and EU GMP, to enhance market access and competitiveness.

Buyer Due Diligence Brief — Evaluating Stericon Pharma Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Stericon Pharma demonstrates a strong track record in pharmaceutical manufacturing, with a portfolio of over 200 products and a commitment to quality as evidenced by its ISO 13485 and CE certifications. The company's ability to manufacture products for various international clients indicates reliability and consistency in its operations. However, the lack of FDA approvals and WHO prequalification may limit its appeal to certain markets.

2Certifications to Verify

Importers should verify the following certifications when considering Stericon Pharma as a supplier:

ISO 13485 Certification: Confirms compliance with international quality management standards for medical devices. Verification can be done by requesting a copy of the certificate from Stericon Pharma.

CE Marking: Indicates conformity with European Union regulations for medical devices. Importers can verify this by checking the CE mark on the product packaging or by requesting documentation from the company.

Frequently Asked Questions — Stericon Pharma Private Limited

How many pharmaceutical products does Stericon Pharma Private Limited export from India?

Stericon Pharma Private Limited exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Vati ($639.5K), Natural ($411.0K). Total export value is $1.1M.

What is Stericon Pharma Private Limited's total pharmaceutical export value?

Stericon Pharma Private Limited's total pharmaceutical export value is $1.1M, based on 33 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Stericon Pharma Private Limited cover?

Stericon Pharma Private Limited exports across 1 therapeutic categories. The largest are Ayurvedic & Herbal Products (100.0%, 2 products).

Get Full Stericon Pharma Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.